Open in TheBrain

Streptomycin

Streptomycin is a well-known antibiotic that has played a significant role in the treatment of bacterial infections since its discovery. It is particularly notable for being the first antibiotic used to treat tuberculosis (TB) and has a rich history in the field of medicine.

Discovery and Development

Streptomycin was discovered in 1943 by Selman Waksman, Albert Schatz, and Elizabeth Bugie at Rutgers University. This discovery was groundbreaking as it marked the beginning of a new era in the treatment of infectious diseases. Streptomycin was the first antibiotic to be isolated from a soil bacterium, Streptomyces griseus, which belongs to the actinomycetes group. The discovery of streptomycin earned Waksman the Nobel Prize in Physiology or Medicine in 1952.

Mechanism of Action

Streptomycin works by inhibiting protein synthesis in bacteria. It binds to the 30S subunit of the bacterial ribosome, causing a misreading of mRNA. This misreading leads to the production of faulty proteins, which ultimately results in the death of the bacterial cell. Streptomycin is classified as an aminoglycoside antibiotic, a group known for their ability to target gram-negative bacteria.

Clinical Uses

Streptomycin has a range of clinical applications, primarily in the treatment of:

Administration and Dosage

Streptomycin is typically administered via intramuscular injection. The dosage and duration of treatment depend on the type and severity of the infection, as well as the patient's age and kidney function. It is crucial to follow medical guidance when using streptomycin to minimize the risk of side effects and resistance.

Side Effects and Precautions

While streptomycin is effective, it is not without side effects. Some of the potential side effects include:

Due to these potential side effects, streptomycin is used with caution, and patients are monitored closely during treatment. It is contraindicated in individuals with known hypersensitivity to aminoglycosides.

Resistance and Challenges

The emergence of antibiotic resistance is a significant challenge in the use of streptomycin. Bacteria can develop resistance through various mechanisms, such as modifying the target site, enzymatic inactivation, or efflux pumps that expel the antibiotic from the cell. To combat resistance, streptomycin is often used in combination with other antibiotics, especially in the treatment of TB.

Attachments